Erlotero 100 mg Tablet
  1. Home
  2. Pharma Products
  3. Hetero Healthcare Ltd
  4. Erlotero 100 mg Tablet

Erlotero 100 mg Tablet

Erlotero 100 mg Tablet contains erlotinib 100 mg and is an oral targeted anticancer medicine. It is used for EGFR-positive non-small cell lung cancer and, in combination with other medicines, for pancreatic cancer. The tablet should be used only as prescribed by a qualified oncologist.

BUY NOW

Category

Erlotinib belongs to the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor class and works by blocking EGFR signaling involved in cancer-cell growth. It may help slow the progression of cancers driven by specific EGFR signaling abnormalities. Erlotero should generally be taken on an empty stomach, at least 1 hour before or 2 hours after food. Regular medical monitoring may be required because treatment can cause rash, diarrhea, fatigue, liver-related effects, and other adverse reactions.

Technical Specification

Specification Details
Active Ingredient Erlotinib Hydrochloride equivalent to Erlotinib
Strength 100 mg
Dosage Form Tablet
Pack Size 30 tablets
Route of Administration Oral
Manufacturer Hetero Healthcare Limited

Product Also Known As

Erlotero 100mg Tablet, Erlotero 100 mg Tablet, Erlotero 100 Tablet, Erlotinib 100mg Tablet, Erlotinib 100 mg Tablet, Erlotinib Hydrochloride 100mg Tablet, Erlotinib Oral Tablet